Summary
- Current Price
- As of today, MGNX price is $4.74, up +3.51% in the most recent trading session on
- Current Price All-Time High
- MGNX price is currently -88.44% below its historical high of $41.00 set on
- Market Cap
- MGNX current market cap is $301M, up +261.84% over the past 365 days
- PE Ratio
- MGNX PE ratio is unknown
- Revenue
- MGNX current annual revenue is $149.50M, down -0.31% year-over-year
- Next Earnings
- The next earnings release for MGNX is on
Profile
| Metric | Value |
|---|---|
| Full Name | MacroGenics, Inc. |
| Ticker | NASDAQ: MGNX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | macrogenics.com |
| Employees | 341 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $4.74 | ||
| Price, 1D Change | +3.51% | |
| $301M | ||
| - | ||
| - | ||
| 1.36 | ||
| $150M | ||
| Revenue, 1Y Change | -0.31% | |
| -$1.18 | ||
| EPS, 1Y Change | -10.48% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.18 | ||
| EPS Estimate | N/A | $0.04 |
| EPS Est. Change | N/A | +102.96% |
| $149.50M | ||
| Revenue Estimate | N/A | $164.39M |
| Revenue Est. Change | N/A | +9.96% |
| $4.74 | ||
| Price Target | - | $7.00 |
| Price Tgt. Change | - | +47.66% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.42 | -$1.07 | +24.42% | |
| -$0.89 | -$1.18 | -33.50% | |
| $0.04 | N/A | +102.96% | |
| -$1.41 | N/A | -19.62% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $164.78M | $149.96M | -8.99% | |
| $136.12M | $149.50M | +9.83% | |
| $164.39M | N/A | +9.96% | |
| $94.26M | N/A | -36.95% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +259.14% | ||
| -17.41% | ||
| +261.84% | ||
| -15.11% | ||
| -0.31% | ||
| -1.61% | ||
| -10.48% | ||
| +39.39% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $4.74 | ||
| $2.35 | ||
| $3.73 | ||
| $2.78 | ||
| $3.73 | ||
| $0.11 | ||
| 1.36 | ||
| $0.29 | ||
| 64.94 | ||
| 71.97% | ||
| 92.38% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $149.50M | ||
| -$1.18 | ||
| $106.32M | ||
| 71.12% | ||
| -$72.84M | ||
| -48.72% | ||
| -$74.62M | ||
| -49.91% | ||
| -$65.67M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.92 | ||
| 5.10 | ||
| 4.92 | ||
| - | ||
| 2 | ||
| -5.26 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.92 | ||
| 14.22 | ||
| -4.46 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $55.59M | ||
| $189.91M | ||
| $264.57M | ||
| $219.94M | ||
| $208.98M | ||
| $43.12M | ||
| $106.76M | ||
| $5.18M | ||
| $4.79M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $224.12M | ||
| $179.16M | ||
| $43.18M | ||
| $0.00 | ||
| $7.17M | ||
| $0.00 | ||
| -$672.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$81.04M | ||
| -$114.10M | ||
| $69.51M | ||
| $1.91M | ||
| -$82.95M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| B. Riley Securities | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| Leerink Partners | → | |
| B. Riley Securities | → | |
| Stifel | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| JMP Securities | → |
Analyst sentiment
Institutional ownership
Screeners with MGNX
FAQ
What is the ticker symbol for MacroGenics, Inc.?
The ticker symbol for MacroGenics, Inc. is NASDAQ:MGNX
Does MacroGenics, Inc. pay dividends?
No, MacroGenics, Inc. does not pay dividends
What sector is MacroGenics, Inc. in?
MacroGenics, Inc. is in the Healthcare sector
What industry is MacroGenics, Inc. in?
MacroGenics, Inc. is in the Biotechnology industry
What country is MacroGenics, Inc. based in?
MacroGenics, Inc. is headquartered in United States
When did MacroGenics, Inc. go public?
MacroGenics, Inc. initial public offering (IPO) was on October 10, 2013
Is MacroGenics, Inc. in the S&P 500?
No, MacroGenics, Inc. is not included in the S&P 500 index
Is MacroGenics, Inc. in the NASDAQ 100?
No, MacroGenics, Inc. is not included in the NASDAQ 100 index
Is MacroGenics, Inc. in the Dow Jones?
No, MacroGenics, Inc. is not included in the Dow Jones index
When was MacroGenics, Inc. last earnings report?
MacroGenics, Inc.'s most recent earnings report was on May 13, 2026
When does MacroGenics, Inc. report earnings?
The next expected earnings date for MacroGenics, Inc. is August 13, 2026
Data Sources & References
- MGNX Official Website www.macrogenics.com
- MGNX Profile on Yahoo Finance finance.yahoo.com/quote/MGNX
- MGNX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mgnx